<DOC>
	<DOCNO>NCT00773604</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness deep brain stimulation ( DBS ) subthalamic nucleus ( STN ) primary dystonia .</brief_summary>
	<brief_title>Deep Brain Stimulation Patients With Dystonia</brief_title>
	<detailed_description>Dystonia uncommon brain disorder abnormal muscle tone produce twisting , writhe movement abnormal posture . It associate abnormal electrical activity two group nerve cell brain call globus pallidus internus ( GPi ) subthalamic nucleus ( STN ) . Deep brain stimulation ( DBS ) show effective treatment patient medically refractory dystonia currently approve GPi STN target humanitarian device exemption ( HDE ) use segmental generalized primary dystonia well focal cervical dystonia . GPi DBS appear effective medication-refractory focal segmental dystonia affect cranial cervical region open-label series , recently GPi stimulation associate subtle motor disturbance previously non-dystonic body region ( i.e. , arm legs ) population patient . DBS STN also report effective treating generalize cervical dystonia small open label trial . STN DBS cranial cervical region may provide similar efficacy treatment dystonia GPi DBS , without unwanted stimulation-induced motor effect . Objectives study 1 ) evaluate safety efficacy STN DBS dystonia ; 2 ) determine time course STN potential efficacy optimal stimulation parameter ; 3 ) determine frequency severity stimulation-induced motor adverse effect previously non-dystonic body region . Twenty-five patient screen , consent , enrol study . All patient undergo bilateral STN DBS dystonia . Participants evaluate pre- postoperatively standard dystonia rating scale include Burke-Fahn-Marsden Dystonia rating scale ( BFMDRS ) , Toronto Western Spasmodic Torticollis Rating Scale ( TWSTRS ) , Jankovic Rating Scale ( JRS ) , Clinical Global Improvement ( CGI ) rating scale . Changes cognitive function assess neuropsychological testing . Stimulation parameter document , patient questionnaire administer postoperatively determine patient experience stimulation-induced motor adverse effect . Patient weight record study visit . This pilot study provide preliminary open label efficacy outcomes STN DBS treatment primary dystonia help determine target compare GPi DBS large double-blind trial .</detailed_description>
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<criteria>Refractory primary dystonia diagnose movement disorder neurologist Severe functional impairment despite optimal medical management , include fail botulinum toxin therapy Age 780 year ( UCSF patient ) 1880 ( VA patient ) Patients consider high risk elective neurosurgery comorbid condition Brain MRI show extensive brain atrophy small vessel ischemic disease Pregnancy Inability tolerate awake microelectrodeguided neurosurgery Inability follow postoperative study visit Inability speak read English Patients score 4.5 low BFMDRS movement scale Patients Secondary dystonia</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>blepharospasm</keyword>
	<keyword>Deep brain Stimulation</keyword>
	<keyword>cervical dystonia</keyword>
	<keyword>cranial dystonia</keyword>
	<keyword>generalize dystonia</keyword>
	<keyword>subthalamic nucleus</keyword>
	<keyword>DBS</keyword>
</DOC>